BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $102,000 | +12.1% | 30,400 | -2.6% | 0.05% | +2.1% |
| Q4 2018 | $91,000 | -52.6% | 31,200 | 0.0% | 0.05% | -36.8% |
| Q3 2018 | $192,000 | -16.5% | 31,200 | 0.0% | 0.08% | -16.5% |
| Q2 2018 | $230,000 | +12.7% | 31,200 | 0.0% | 0.09% | +19.7% |
| Q1 2018 | $204,000 | -22.1% | 31,200 | 0.0% | 0.08% | -20.0% |
| Q4 2017 | $262,000 | -42.8% | 31,200 | -21.4% | 0.10% | -48.6% |
| Q3 2017 | $458,000 | – | 39,700 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 918,000 | $11,328,000 | 4.35% |
| EMORY UNIVERSITY | 164,607 | $2,031,000 | 1.92% |
| Monashee Investment Management LLC | 160,000 | $1,974,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 210,260 | $2,595,000 | 0.65% |
| CORRADO ADVISORS, LLC | 83,622 | $1,032,000 | 0.59% |
| Foresite Capital Management II, LLC | 105,000 | $1,296,000 | 0.56% |
| Baker Brothers Advisors | 5,032,313 | $62,099,000 | 0.51% |
| SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $2,468,000 | 0.48% |
| Clearline Capital LP | 55,200 | $681,000 | 0.32% |
| LMR Partners LLP | 270,594 | $3,339,000 | 0.32% |